The Debate Over the COVID-19 Test to Treat Program
The Test to Treat initiative was launched in March 2022 in an effort to provide Americans with immediate access to COVID-19 treatments. It allows someone who tests positive for COVID-19 to receive treatment at select pharmacies, long-term care facilities, and Federally Qualified Health Centers (FQHC). In response, the American Medical Association (AMA) and American Pharmacists Association (APhA) both issued statements taking a stance on the initiative. Here, we’ll look at the details of the Test to Treat program and also the opinions of the AMA and APhA.